XNAS · PRCT
-9.00% · -$1.91 · Vol 1.9M
Market closed · last close 4:00 PM ET · price as of 19:59:42 ET
PROCEPT BioRobotics Corporation Common Stock

PROCEPT BioRobotics Corporation Common Stock

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$19.31
+ Add to watchlist
Card
Relationship Map

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

Score not reportedVeridion does not publish a score-history trend for PRCT until the ticker has a real scored snapshot. No trend is implied for this page.Review methodology
NO SCORE SNAPSHOT COVERAGE
AI Analysis
Sovereign

Why is PRCT moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for PRCT are being assembled.
About PROCEPT BioRobotics Corporation Common Stock
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed since
2021
Employees
888
Country
US

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$20.64
Day high
$21.18
Day low
$18.66
Previous close
$21.22
52W high
$21.18
-8.81% from high
52W low
$18.66
26% of range
Market cap
$1.2B
EPS
$-1.6800
Shares out
56.9M
Volume
1.9M
VWAP
$19.16
Price history computed in-house
SMA 50 Not reported · Not reported
SMA 200 Not reported · Not reported
52W position 26%
Veridion warehouse edge

Warehouse intelligence for PRCT.

Veridion Score
Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Related public evidence

Continue the PRCT research trail.

Relationship mapTrace receipt-backed holders and filings around PRCT.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

PRCT insider activity

PROCEPT BioRobotics Corporation Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for PRCT.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

PRCT contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PRCT in this window.
Lobbying spend

PRCT lobbying filings, year to date.

Registered lobbying filings matched to PROCEPT BioRobotics Corporation Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PRCT in this window.
Latest news · PRCT
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for PRCT.
Options
Sovereign unlock shows live options positioning for PRCT.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.